Millions of dollars in federal funding were restored to a massive construction project along the Hudson River over the weekend, but hundreds of millions more remained in dispute after the Trump ...

NEW YORK (WABC) -- Officials in New Jersey and New York will have to wait a few more days to receive the stalled $205 million in funding for the Gateway Tunnel project. During a court conference on ...

The United Gateway℠ Card is the most approachable entry point into United’s credit card ecosystem. After flying nearly a million miles and reviewing nearly every tier of United’s lineup of credit ...

Payments for the $16 billion rail tunnel between New York City and New Jersey had been suspended for more than four months. By Patrick McGeehan Federal funding for the $16 billion Gateway rail tunnel ...

A federal appeals court allowed a judge’s order to take effect Thursday that requires the Trump administration to resume funding for the Gateway tunnel project connecting New York and New Jersey. By ...

Construction on the $16 billion Gateway Tunnel Project remained paused Monday morning despite a federal judge temporarily blocking the freezing of funds by the Trump administration. A temporary ...

A federal judge had ordered the funding for a $16 billion tunnel project restored last week, but on Monday granted a temporary stay after the federal government appealed her decision. By Patrick ...

The metals producer says land beneath its former Hawesville, Kentucky, smelter has been sold to a company that plans to build a data center. Smelter site buyer Terawulf describes itself as a company ...

The ruling comes after New York and New Jersey filed a lawsuit against the Trump administration to release billions in frozen funding for the Gateway Tunnel project. The project is the nation's ...

The Federal Trade Commission has announced what it called a "landmark settlement" with Express Scripts over insulin pricing. The settlement resolves a lawsuit alleging that Express Scripts' conduct ...

The FTC first sued Express Scripts, CVS Caremark, and Optum in 2024, claiming anticompetitive and unfair rebating practices surrounding insulin. “Caremark, [Express Scripts], and Optum—as medication ...